Chapter 144 – Vitreous Anatomy and Pathology
• Vitreous is an extended extracellular matrix of approximately 4.0?ml in volume and 16.5?mm in axial length (emmetropia) that is situated between the lens and retina.
• The clear vitreous gel fills the center of the eye, modulates growth of the eye, maintains media transparency, and during aging detaches away from the retina, in most cases innocuously.
• Anomalous posterior vitreous detachment is the fundamental cause of rhegmatogenous retinal detachment and vitreo-maculopathies, and plays an important role in proliferative diabetic vitreo-retinopathy.
Although vitreous is the largest structure within the eye, constituting 80% of the ocular volume, investigators of vitreous anatomy are hampered by two fundamental difficulties:
• Any attempts to define vitreous morphology are efforts to “visualize” a tissue that is invisible by design ( Fig. 144-1 ).
• The various techniques that were employed previously to define vitreous structure were flawed by artifacts induced by tissue fixatives, which caused precipitation of hyaluronan (formerly called hyaluronic acid), a glycosaminoglycan.
The development of slit-lamp biomicroscopy by Gullstrand in 1912 was expected to enable clinical investigation of vitreous structure without the introduction of the aforementioned artifacts. Yet, a widely disparate set of descriptions resulted because of the first of the inherent difficulties just described; that is, the vitreous body, by design, is largely invisible. This problem even persists in so-called modern investigations. Consider, for example, that in the 1970s Eisner described “membranelles” and Worst “cisterns,” in the 1980s Sebag and Balazs  identified “fibers,” and in the 1990s Kishi and Shimizu found “pockets” in the vitreous body. The discrepant observations of the last-mentioned group have now been explained largely as an age-related phenomenon with no relevance to the inherent macromolecular structure or anatomy. 
In the following, vitreous anatomy is characterized in terms of its molecular constituents and their macromolecular organization, the resultant macroscopic morphology, and the effects of major disease processes on vitreoretinal pathology.
As shown in Fig. 144-2 , individual vitreous collagen fibrils are organized as a triple helix of three alpha chains. The major collagen fibrils of the vitreous body are heterotypic, consisting of
Figure 144-1 Vitreous obtained at autopsy from a 9-month-old child. The sclera, choroid, and retina were dissected off the transparent vitreous, which remains attached to the anterior segment. A band of gray tissue can be seen posterior to the ora serrata. This is neural retina that was firmly adherent to the vitreous base and could not be dissected. The vitreous is almost entirely gel (because of the young age of the donor) and thus is solid and maintains its shape, although situated on a surgical towel exposed to room air. (Courtesy of the New England Eye Bank, Boston, MA.)
more than one collagen type. Studies of pepsinized forms of collagen confirm that the vitreous body contains collagen type II, a hybrid of types V and XI, and type IX. Considerable similarities exist between vitreous collagen, the major collagen fibrils of articular cartilage, and the nucleus pulposus of the spine. This may explain why some clinical phenomena occur simultaneously in these different tissues.
TYPE II COLLAGEN.
Total vitreous collagen is 75% type II collagen. It is a homotrimer, composed of three identical alpha chains designated as [1(II)]3 . When first synthesized as a procollagen and secreted into the extracellular space, type II collagen is highly soluble. The activity of N-proteinase and C-proteinase enzymes reduces the solubility and enables type II collagen molecules to cross-link covalently in a quarter-staggered array. Within this array are likely to be N-propeptides, which probably extend outward from the surface of the forming fibril. This may influence the interaction of the collagen fibril with other components of the extracellular matrix. That type IIA procollagen propeptides specifically bind transforming growth factor-ß1 and BMP-2 supports the concept that in certain circumstances such growth factors and cytokines interact with vitreous fibrils to promote the cell migration and proliferation that result in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
TYPE IX COLLAGEN.
Type IX collagen is a heterotrimer that is disulfide bonded with an [a1(IX)a2(IX)a3(IX)] configuration. This heterotrimer is oriented regularly along the surfaces of the major collagen fibrils in a “D periodic” distribution, where it is cross-linked onto the fibril surface. Type IX is not a typical
Figure 144-2 The triple helix configuration of the collagen molecule. Individual alpha chains are left-handed helices with approximately three residues per turn. The chains themselves, however, are coiled around each other in a right-handed twist. The triple helix configuration is stabilized by hydrogen bonds, which form between opposing residues in different chains (interpeptide hydrogen bonding). (Reprinted with permission from Nimni ME, Harkness RD. Molecular structure and functions of collagen. In: Nimni ME, ed. Collagen, Vol 1. Boca Raton, FL: CRC Press; 1988.)
collagen but is a member of the FACIT (fibrillar-associated collagens with interrupted triple helixes) group of collagens. It contains collagenous regions described as COL1, COL2, and COL3 interspersed between noncollagenous regions called NC1, NC2, NC3, and NC4.  In vitreous (as opposed to cartilage) the NC4 domain is small and, therefore, not highly charged and not likely to exhibit extensive interaction with other extracellular matrix components. In vitreous, type IX collagen always contains a chondroitin sulfate glycosaminoglycan chain,  which is linked covalently to the a2(IX) chain at the NC3 domain; this enables the molecule to assume a proteoglycan form. Duplexing of glycosaminoglycan chains from adjacent collagen fibrils may result in a “ladder-like” configuration. 
TYPE V/XI COLLAGEN.
Ten percent of vitreous collagen is a hybrid V/XI collagen that is believed to constitute the central core of the major collagen fibrils of vitreous. Type V/XI is a heterotrimer that contains 1(XI) and 2(V) in two chains; the nature of the third chain is not yet known. Along with type II collagen, type V/XI is a fibril-forming collagen. Although, in cartilage, the interaction of the fibril with other extracellular matrix components is probably influenced by a retained N-propeptide  that protrudes from the surface of the fibril, it is not known whether this is the case in vitreous.
TYPE VI COLLAGEN.
Although there are only small amounts of type VI collagen in vitreous, the ability of this molecule to bind both type II collagen and hyaluronan suggests that it could be important in organizing and maintaining the supramolecular structure of vitreous gel.
Hyaluronan is found throughout the body, but it was first isolated from bovine vitreous. In human vitreous, hyaluronan first appears after birth and is believed to be synthesized primarily by hyalocytes, although other plausible candidates exist, such as the ciliary body and retinal Müller cells. Whereas the synthesis of hyaluronan seems to stabilize at a constant level in the adult, no extracellular degradation occurs. Levels of hyaluronan remain constant because it escapes from vitreous via the anterior segment of the eye and because of reuptake by hyalocytes.
Hyaluronan is a long, unbranched polymer of repeating disaccharide (glucuronic acid-1,3-N,N-acetylglucosamine) linked by 1–4 bonds. It is a linear, left-handed, three-fold helix with a rise per disaccharide on the helix axis of 0.98?nm. Rotary shadowing electron microscopy of human and bovine vitreous demonstrates lateral aggregates of hyaluronan that form an anastomosing three-dimensional network. This periodicity varies depending on whether the helix is in a “compressed” or “extended” configuration.
The sodium salt of hyaluronan has a molecular weight of 3–4.5 × 106 in normal human vitreous. Recent studies used dynamic light scattering in bovine vitreous and found a weight-averaged molecular weight of 170,000. Although there is no evidence that adjacent hyaluronan chains bind to one another, rotary shadowing electron microscopy of bovine and human vitreous found lateral aggregates of hyaluronan that formed three-dimensional lattice-like networks.
The volume of the unhydrated hyaluronan molecule is about 0.66?cm3 /g, whereas the hydrated specific volume is 2000–3000?cm3 /g.  Thus, the degree of hydration has a significant influence on the size and configuration of the molecular network. Furthermore, as a result of its entanglement and immobilization in tissue, hyaluronan interacts with the surrounding mobile ions and thus undergoes changes in its conformation.  A decrease in surrounding ionic strength can cause the anionic charges on the polysaccharide backbone to repel one another, which results in an extended configuration of the macromolecule. In this way, changes in the ionic milieu of vitreous may be converted into mechanical energy through extension or contraction of the hyaluronan macromolecule and, in turn, swelling or shrinkage of the vitreous body. This can be important in certain pathological conditions, such as diabetes.
Another important property of hyaluronan is that of steric exclusion.  Hyaluronan, with its flexible linear chains and random coil conformation, occupies a large volume and resists the penetration of this volume by other molecules to a degree dependent upon their size and shape. This “excluded volume” effect can influence equilibria between different conformational states of macromolecules and alter the compactness or extension of these molecules. Steric exclusion also causes an excess of osmotic pressure when such compounds as albumin and hyaluronan are mixed because the resultant osmotic pressure is greater than the sum of the two components. This could be important in diabetes, in which vascular incompetence can increase vitreous concentrations of serum proteins such as albumin. Thus, osmotic effects can induce contraction and expansion of the vitreous body, which can in turn play an important role in neovascularization and vitreous hemorrhage. An increase in the chemical activity of a compound because of steric exclusion can cause its precipitation if the solubility limit is reached. This could be important in the formation of pathological vitreous opacities, such as asteroid hyalosis and amyloidosis. 
Vitreous contains two chondroitin sulfate proteoglycans. The minor type is actually type IX collagen, which has already been described. The majority of vitreous chondroitin sulfate is in the form of versican. This large proteoglycan has a globular N-terminal that binds hyaluronan via a 45?kDa link protein. In human vitreous, versican is believed to form complexes with hyaluronan as well as microfibrillar proteins such as fibulin-1 and fibulin-2.
Noncollagenous Structural Proteins
Fibrillin-containing microfibrils are more abundant than the type VI collagen microfibrils described earlier. They are found in vitreous gel as well as the zonules of the lens. This fact explains why in Marfan’s syndrome the defects in the gene encoding fibrillin-1 (FBN1 on chromosome 15q21) result in both ectopia lentis and vitreous liquefaction. The latter probably plays a role in the frequent occurrence of rhegmatogenous retinal detachment in these patients, through anomalous posterior vitreous detachment.
The major noncollagenous protein of vitreous is a leucine-rich repeat (LRR) protein that is bound to the surface of the heterotypic collagen fibrils, known as opticin. Formerly called vitrican, opticin is believed to be important in collagen fibril assembly and in preventing the aggregation of adjacent collagen fibrils into bundles. Thus, a breakdown in this property or activity may play a role in the age-related changes described later in this chapter.
Another novel vitreous protein is VIT1, a collagen-binding macromolecule. Because of its propensity to bind collagen, this highly basic protein may play an important role in maintaining vitreous gel structure.
Miscellaneous Molecular Components
Amino acids are present in vitreous, perhaps to serve as a metabolic repository for lens and/or retinal protein metabolism. Albumin, transferrin,  and metalloproteinases are also present. Glycoproteins, which are heteropolysaccharides as opposed to the homogeneous, repeating disaccharide units of glycosaminoglycans, are found in relatively large quantities. Cartilage oligomeric protein (COMP), an acidic glycoprotein with a characteristic five-armed structure, is present in vitreous, although its function is unknown.
Vitreous ascorbic acid may serve as a free radical scavenger to protect the retina and lens from the untoward effects of metabolic and light-induced singlet oxygen generation and oxidative damage as a result of inflammation. Lipids, phospholipids, and many different low-molecular-weight components, as well as several ions, are present in vitreous. 
Vitreous is composed of a dilute meshwork of collagen fibrils with interspersed extensive arrays of long hyaluronan molecules. The collagen fibrils provide a solid structure that is “inflated” by the hydrophilic hyaluronan. If collagen is removed, the remaining hyaluronan forms a viscous solution; if hyaluronan is removed, the gel shrinks but is not destroyed. Physiological observations also suggest the existence of an important interaction between hyaluronan and collagen. It has been hypothesized that the hydroxylysine amino acids of collagen mediate polysaccharide binding to the collagen chain through O-glycosidic linkages. These polar amino acids are present in clusters along the collagen molecule, which perhaps explains why proteoglycans attach to collagen in a periodic pattern.
Hyaluronan-collagen interaction in the vitreous body may be mediated by a third molecule. In cartilage, “link glycoproteins” have been identified that interact with proteoglycans and hyaluronan. Supramolecular complexes of these glycoproteins are believed to occupy the interfibrillar spaces. Bishop has elegantly described the potential roles of type IX collagen chondroitin sulfate chains, hyaluronan, and opticin in the short-range spacing of collagen fibrils and how these mechanisms might break down in aging and disease.
Many investigators believe that hyaluronan-collagen interaction occurs on a “physicochemical” rather than a “chemical” level.  Reversible formation of complexes of an electrostatic nature between solubilized collagen and various glycosaminoglycans occurs. Electrostatic binding in vitreous could occur between negatively charged hyaluronan and positively charged collagen. 
In an emmetropic adult human eye the vitreous body is approximately 16.5?mm in axial length with a depression anteriorly just behind the lens (patellar fossa). The hyaloideocapsular ligament of Weiger is the annular region (1–2?mm in width and 8–9?mm
Figure 144-3 Vitreous anatomy according to classical anatomical and histological studies. (Reprinted with permission from Schepens CL, Neetens A, eds. The vitreous and vitreoretinal interface. New York: Springer-Verlag; 1987:20.)
in diameter) where the vitreous body is attached to the posterior aspect of the lens. Erggelet’s or Berger’s space is at the center of the hyaloideocapsular ligament. The canal of Cloquet arises from this space and courses posteriorly through the central vitreous ( Fig. 144-3 ), which is the former site of the hyaloid artery in the embryonic vitreous. The former lumen of the artery is an area devoid of collagen fibrils and surrounded by multifenestrated sheaths that were previously the basal laminae of the hyaloid artery wall. Posteriorly, Cloquet’s canal opens into a funnel-shaped region anterior to the optic disc, known as the area of Martegiani.
Within the adult human vitreous fine, parallel fibers course in an anteroposterior direction, are continuous, and do not branch ( Fig. 144-4 ). The fibers arise from the vitreous base, where they insert anterior and posterior to the ora serrata. Various concepts are used to explain the connection between the peripheral anterior vitreous fibers and the retina and pars plana, but all agree that the pathophysiology of retinal tears is vitreous traction upon foci of strong adhesion at the vitreoretinal interface in these locations.
As the central fibers near the vitreous cortex course posteriorly, they are circumferential with the vitreous cortex, while central fibers “undulate” in a configuration parallel to Cloquet’s canal. Ultrastructural studies demonstrate that collagen, organized in bundles of packed, parallel fibrils, is the only microscopic structure that corresponds to these fibers. It is hypothesized that visible vitreous fibers form when hyaluronan molecules no longer separate the microscopic collagen fibrils, which results in the aggregation of collagen fibrils into bundles from which hyaluronan molecules are excluded.   The areas adjacent to these large fibers have a low density of collagen fibrils and a relatively high concentration of hyaluronan molecules. Composed primarily of “liquid vitreous,” these areas scatter very little incident light and, when prominent, constitute “lacunae” seen in aging (see Fig. 144-5 ).
Figure 144-4 The eye of a 57-year-old man after dissection of the sclera, choroid, and retina, with the vitreous still attached to the anterior segment. The specimen was illuminated with a slit-lamp beam shone from the side and the view here is at a 90° angle to this plane to maximize the Tyndall effect. The anterior segment is below and the posterior pole is at the top of the photograph. A large bundle of prominent fibers courses anteroposteriorly to exit via the premacular dehiscence in the vitreous cortex.
Figure 144-5 Human vitreous in old age. The central vitreous has thickened, tortuous fibers. The peripheral vitreous has regions devoid of any structure, which contain liquid vitreous. These regions correspond to “lacunae,” as seen clinically using biomicroscopy (arrows).
The vitreous cortex is defined as the peripheral “shell” of the vitreous body that courses forward and inward from the anterior vitreous base, the “anterior vitreous cortex,” and posteriorly from the posterior border of the vitreous base, the “posterior vitreous cortex.” The posterior vitreous cortex is 100–110?µm thick and consists of densely packed collagen fibrils.  Although no direct connections exist between the posterior vitreous and the retina, the posterior vitreous cortex is adherent to the internal limiting lamina of the retina, which is actually the basal lamina of retinal Müller cells. The exact nature of the adhesion between the posterior vitreous cortex and the internal limiting lamina is not known, but it most probably results from the action of various extracellular matrix molecules.
A hole in the prepapillary vitreous cortex can sometimes be visualized clinically when the posterior vitreous is detached from the retina ( Fig. 144-6 ). If peripapillary glial tissue is torn away during posterior vitreous detachment and remains attached to the vitreous cortex about the prepapillary hole, it is referred to as Vogt’s or Weiss’ ring. Vitreous can extrude through the prepapillary hole in the vitreous cortex but does so to a lesser
Figure 144-6 Fundus view of posterior vitreous detachment. A, The posterior vitreous in the left eye of this patient is detached and the prepapillary hole in the posterior vitreous cortex is anterior to the optic disc (arrows, slightly below and to the left of the optic disc here). B, A slit beam illuminates the retina and optical disc (at bottom) in the center. To the right is the detached vitreous. The posterior vitreous cortex is the dense, whitish gray, vertically oriented linear structure to the right of the slit beam. (Courtesy of CL Trempe, MD.)
extent than through the premacular vitreous cortex. Various vitreo-maculopathies can result. Other mechanisms, particularly tangential vitreo-macular traction, are implicated in the pathogenesis of macular holes.
Embedded within the posterior vitreous cortex are hyalocytes. These mononuclear cells are spread widely apart in a single layer situated 20–50?µm from the internal limiting membrane of the retina. The highest density of hyalocytes is in the vitreous base, followed next by the posterior pole, with the lowest density at the equator. Hyalocytes are oval or spindle shaped, 10–15?µm in diameter, and contain a lobulated nucleus, a well-developed Golgi complex, smooth and rough endoplasmic reticula, many large lysosomal granules (periodic acid–Schiff positive), and phagosomes ( Fig. 144-7 ). Balazs pointed out that hyalocytes are located in the region of highest hyaluronan concentration and suggested that these cells are responsible for hyaluronan synthesis. Hyalocyte capacity to synthesize collagen was first demonstrated by Newsome et al. Thus, in a similar fashion to the chondrocyte metabolism in the joint, hyalocytes may be responsible for vitreous collagen synthesis at some point(s) during life. The phagocytic capacity of hyalocytes is consistent with the presence of pinocytic vesicles and phagosomes and the presence of surface receptors that bind immunoglobulin G and complement. It is intriguing to consider that hyalocytes are among the first cells to be exposed to any migratory or mitogenic stimuli during various disease states, particularly proliferative vitreoretinopathy.
Figure 144-7 Ultrastructure of human hyalocyte. A mononuclear cell is embedded within the dense collagen fibril (CF) network of the vitreous cortex. There is a lobulated nucleus (N) with a dense marginal chromatin (C). In the cytoplasm there are mitochondria (M), dense granules (arrows), vacuoles (V), and microvilli (MI). (Courtesy of Joe Craft and DM Albert, MD.)
Therefore, the role of these cells must be considered when the pathophysiology of all proliferative disorders at the vitreoretinal interface is considered, including premacular membrane formation.
The basal laminae about the vitreous body are composed of type IV collagen closely associated with glycoproteins. At the pars plana, the basal lamina has a true lamina densa. The basal lamina posterior to the ora serrata is the internal limiting lamina of the retina. The layer immediately adjacent to the Müller cell is a lamina rara, which is 0.03–0.06?µm thick. The lamina densa is thinnest at the fovea (0.01–0.02?µm) and disc (0.07–0.1?µm). It is thicker elsewhere in the posterior pole (0.5–3.2?µm) than at the equator or vitreous base.  The anterior surface of the internal limiting lamina (vitreous side) is normally smooth, whereas the posterior aspect is irregular, as it fills the spaces created by the irregular surface of the subjacent retinal glial cells. This feature is most marked at the posterior pole, whereas in the periphery both the anterior and posterior aspects of the internal limiting lamina are smooth. The significance, if any, of this topographic variation is not known. At the rim of the optic disc the retinal internal limiting lamina ceases, although the basal lamina continues as the “inner limiting membrane of Elschnig.” This membrane is 50?µm thick and is believed to be the basal lamina of the astroglia in the papilla. At the central-most portion of the optic disc the membrane thins to 20?µm, follows the irregularities of the underlying cells of the optic nerve head, and is composed only of glycosaminoglycans with no collagen. This structure is known as the “central meniscus of Kuhnt.” The thinness and chemical composition of these structures may account for, among other phenomena, the frequency with which abnormal cell proliferation arises from or near the optic disc in proliferative diabetic retinopathy and premacular membranes with macular pucker.
The vitreous is known to be most firmly attached at the vitreous base, disc, and macula and over retinal blood vessels. The posterior aspect (retinal side) of the internal limiting lamina demonstrates irregular thickening the farther posteriorly from the ora serrata.  So-called attachment plaques between the Müller cells and the internal limiting lamina have been described in the basal and equatorial regions of the fundus but not in the posterior pole, except for the fovea.  It has been hypothesized that these develop in response to vitreous traction upon the retina. The thick internal limiting lamina in the posterior pole dampens the effects of this traction, except at the fovea, where the internal limiting lamina is thin. The thinness of the internal limiting lamina and the purported presence of attachment plaques at the central macula could explain the predisposition of this region to changes induced by traction. An unusual vitreoretinal interface overlies retinal blood vessels. Physiologically, this may provide a shock-absorbing function to dampen arterial pulsations. However, pathologically, this structural arrangement could also account for the proliferative and hemorrhagic events upon retinal blood vessels that are associated with vitreous traction.
Embryology and Postnatal Development
Early in embryogenesis, the vitreous body is filled with blood vessels, the vasa hyaloidea propria. It is not known what stimulates regression of this hyaloid vascular system, but studies have identified a protein native to vitreous that inhibits angiogenesis in experimental models. Teleologically, this seems necessary not only to induce regression of the vascular primary vitreous but also to inhibit subsequent cell migration and proliferation and thereby minimize light scatter and achieve transparency. Identifying the phenomena inherent in this transformation may reveal how to control pathological angiogenesis.
Proper vitreous biosynthesis during embryogenesis depends upon normal retinal development because at least some of the vitreous structural components are synthesized by retinal Müller cells. A clear gel, typical of normal “secondary vitreous,” appears only over normally developed retina. Thus, in various developmental anomalies, such as retinopathy of prematurity (ROP), familial exudative vitreoretinopathy, and related entities, vitreous that overlies undeveloped retina in the peripheral fundus is a viscous liquid and not a gel. The extent of this finding depends, at least in ROP, upon the gestational age at birth, because the younger the individual the less developed retina is present in the periphery, especially temporally. In other, truly congenital conditions, there are inborn errors of collagen metabolism that have now been elucidated. In Stickler syndrome, defects in specific genes have been associated with particular phenotypes,  thus enabling the classification of patients with Stickler syndrome into four subgroups. Patients in the subgroups with vitreous abnormalities are found to have defects in the genes coding for type II procollagen and type V/XI procollagen.
Ongoing synthesis of both collagen and hyaluronan occurs during development to the adult. Because the synthesis of collagen keeps pace with increasing vitreous volume, the overall concentration of collagen within the vitreous body is unchanged during this period of life. Total collagen content in the gel vitreous decreases during the first few years of life and then remains at about 0.05?mg until the third decade. Because collagen concentration does not increase appreciably as the size of the vitreous increases, the network density of collagen fibrils effectively decreases. This potentially could weaken the collagen network and destabilize the gel. However, as net synthesis of hyaluronan
occurs during this time, the dramatic increase in hyaluronan concentration “stabilizes” the thinning collagen network.
Aging of the Vitreous Body
Substantial rheological, biochemical, and structural alterations occur in the vitreous body during aging. After 45–50 years of age a significant decrease occurs in the gel volume and an increase in the liquid volume of human vitreous. These findings were confirmed qualitatively in postmortem studies of dissected human vitreous, and liquefaction was observed to begin in the central vitreous.    Vitreous liquefaction actually begins much earlier than the ages at which clinical examination or ultrasonography detects changes. Postmortem studies found evidence of liquid vitreous in eyes at 4 years of age and observed that by the time the human eye reaches its adult size (age 14–18 years) approximately 20% of the total vitreous volume consists of liquid vitreous. In these postmortem studies of fresh, unfixed human eyes it was observed that after the age of 40 years a steady increase occurs in liquid vitreous simultaneously with a decrease in gel volume. By 80–90 years of age more than half the vitreous body is liquid. The finding that the central vitreous is where fibers are first observed is consistent with the concept that breakdown of the normal hyaluronan-collagen association results in the simultaneous formation of liquid vitreous and aggregation of collagen fibrils into bundles of parallel fibrils, seen as large fibers (see Fig. 144-4 ).    In the posterior vitreous such age-related changes often form large pockets of liquid vitreous, recognized clinically as lacunae,    and mistakenly described as anatomic structures.   
The mechanism of vitreous liquefaction is not understood. Gel vitreous can be liquefied in vivo through the removal of collagen by enzymatic destruction of the collagen network. Endogenous liquefaction may be the result of changes in the minor glycosaminoglycans and chondroitin sulfate profile of vitreous. It has been shown that the injection of chondroitinase ABC can induce liquefaction and “disinsertion” of the vitreous body. Plasmin is another agent being developed as an adjunct to vitreoretinal surgery because of its purported ability to induce liquefaction of the central vitreous and dehiscence at the vitreoretinal interface. Another possible mechanism of vitreous liquefaction is a change in the conformation of hyaluronan molecules with aggregation or cross-linking of collagen molecules. Singlet oxygen can induce conformational changes in the tertiary structure of hyaluronan molecules. Free radicals generated by metabolic and photosensitized reactions could alter hyaluronan and/or collagen structure and trigger a dissociation of collagen and hyaluronan molecules, which ultimately results in liquefaction. This is plausible because the cumulative effects of a lifetime of daily exposure to light may influence the structure and interaction of collagen and hyaluronan molecules by the proposed free radical mechanism(s).
Biochemical studies support the rheologic observations. Total vitreous collagen content does not change after 20–30 years of age. However, in studies of a large series of normal human eyes obtained at autopsy, the collagen concentration in the gel vitreous at 70–90 years of age (approximately 0.1?mg/ml) was greater than at 15–20 years of age (approximately 0.05?mg/ml).  Because the total collagen content does not change, this finding most likely reflects the decrease in the volume of gel vitreous that occurs with aging and consequent increase in the concentration of the collagen that remains in the gel. The collagen fibrils in this gel become packed into bundles of parallel fibrils,    perhaps with cross-links between them. Abnormal collagen cross-links have been identified in the vitreous body of humans who have diabetes, and the findings are consistent with “precocious senescence” of vitreous collagen, a phenomenon that has been described for other organs and tissue in diabetes. 
The structural changes that derive from the aforementioned biochemical and rheologic changes consist of a transition from
Figure 144-8 Vitreous structure in childhood. A, The posterior and central vitreous in a 4-year-old child has a dense vitreous cortex with hyalocytes. A substantial amount of vitreous extrudes into the retrocortical (preretinal) space through the premacular vitreous cortex. However, no fibers are present in the vitreous. B, Central vitreous structure in an 11-year-old child has hyalocytes in a dense vitreous cortex (arrows). No fibers are seen within the vitreous.
a clear vitreous in youth ( Fig. 144-8 ), the consequence of a homogeneous distribution of collagen and hyaluronan, to a fibrous structure in the adult (see Fig. 144-4 ), which results from aggregation of collagen fibrils. In old age advanced liquefaction (see Fig. 144-5 ) occurs with ultimate collapse of the vitreous body and posterior vitreous detachment (PVD).
The vitreous base posterior to the ora increases in size with increasing age to nearly 3.0?mm, to bring the posterior border of the vitreous base closer to the equator. This widening of the vitreous base was found to be most prominent in the temporal portion of the globe. The posterior migration of the vitreous base probably plays an important role in the pathogenesis of peripheral retinal breaks and rhegmatogenous retinal detachment. Within the vitreous base, a “lateral aggregation” of the collagen fibrils is present in older individuals, similar to aging changes within the central vitreous. Recent studies have confirmed posterior migration of the posterior border of the vitreous base during aging. There is also intraretinal synthesis of collagen fibrils that penetrate the internal limiting of the retina and “splice” with vitreous collagen fibrils. These aging changes at the vitreous base could contribute to increased traction on the peripheral retina and to the development of retinal tears and detachment.
Posterior Vitreous Detachment (PVD)
The most common age-related event in the vitreous is PVD. True PVD can be defined as a separation between the posterior vitreous cortex and the internal limiting lamina of the retina; PVD can be localized, partial, or total (up to the posterior border of the vitreous base). Autopsy studies reveal that the incidence of PVD is 63% by the eighth decade, and it is more
common in myopic eyes, in which it occurs on average 10 years earlier than in emmetropic and hyperopic eyes. Cataract extraction in myopic patients introduces additional effects, which caused PVD to develop in all but 1 of 103 myopic (greater than -6D) eyes.
Rheologic changes within the vitreous produce liquefaction, which, in conjunction with weakening of the vitreous cortex–internal limiting laminar adhesion, results in PVD. It is likely that dissolution of the posterior vitreous cortex–internal limiting laminar adhesion at the posterior pole allows liquid vitreous to enter the retrocortical space via the prepapillary hole and perhaps also the premacular vitreous cortex. With rotational eye movements, liquid vitreous can dissect a plane between the vitreous cortex and the internal limiting lamina, which results in true PVD. This volume displacement from the central vitreous to the preretinal space causes the observed collapse of the vitreous body (syneresis). Glare may be induced by PVD because of light scattering by the dense collagen fibril network in the posterior vitreous cortex.
“Floaters” are the most common complaint of patients who have PVD. These usually result from entoptic phenomena caused by condensed vitreous fibers, glial tissue of epipapillary origin (which adheres to the posterior vitreous cortex), and/or intravitreal blood. Floaters move with vitreous displacement during eye movement and scatter incident light, which casts a shadow on the retina that is perceived as a gray, “hair-like” or “fly-like” structure. In 1935, Moore described “light flashes” as a common complaint that results from PVD. Wise noted that light flashes occurred in 50% of cases at the time of PVD; they were usually vertical and temporally located. Voerhoeff suggested that the light flashes result from the impact of the detached vitreous cortex upon the retina during eye movement.
Anomalous Posterior Vitreous Detachment
In addition to the symptoms already described, various untoward effects of PVD can develop if the aforementioned sequence of events occur in an anomalous manner. These anomalies can be grouped into two categories: disruption of retinal tissue and disruption of vitreous.
Vitreous traction upon retinal structures can induce damage to various tissues; the resultant pathology depends upon the type of tissue involved. Lindner found that minimal vitreous hemorrhage occurred in 13–19% of cases with PVD. This finding is generally considered to be an important risk factor for the presence of a retinal tear. Retinal tears result from lesions with firm vitreoretinal adhesion, such as lattice degeneration and rosettes, as well as in areas of the peripheral fundus with no obvious lesions.
A relatively unrecognized form of vitreoretinal separation that can mimic true PVD is called vitreoschisis. It features forward displacement of the anterior portion of the posterior vitreous cortex to leave part or all of the posterior layer of the vitreous cortex still attached to the retina. Vitreoschisis occurs in proliferative diabetic retinopathy and may play an important role in its pathophysiology. Cases of macular pucker and macular holes may also result from persistent attachment of part or all of the posterior vitreous cortex to the macula while the more anterior and central vitreous detaches forward.
METABOLIC DISORDERS OF VITREOUS
In humans who have diabetes, there is an increase in vitreous glucose levels. These elevated levels of glucose are associated with increased nonenzymatic glycation products in human vitreous collagen and elevated levels of the enzyme-mediated cross-link dihydroxylysinonorleucine. Also, considerable diabetic effects may involve hyaluronan. In the daily management
Figure 144-9 Diabetic vitreopathy. A, Right eye of a 9-year-old girl who has a 5-year history of type I diabetes shows extrusion of central vitreous through the posterior vitreous cortex into the retrocortical (preretinal) space. The subcortical vitreous appears very dense and scatters light intensely. Centrally, there are vitreous fibers (arrows) with an anteroposterior orientation and adjacent areas of liquefaction. B, Central vitreous in the left eye of the same patient shows prominent fibers that resemble those seen in nondiabetic adults (see Fig. 144-5 ). (Reprinted with permission from Sebag J. Abnormalities of human vitreous structure in diabetes. Graefes Arch Clin Exp Ophthalmol. 1993;231:257–60.)
of diabetes, significant fluctuations in the systemic concentrations of a variety of molecules may occur, which can alter the ionic milieu of the vitreous body. Shifts in systemic metabolism, and in turn osmolarity and hydration of the vitreous body, could result in periodic swelling and contraction of the entire vitreous body, with consequent traction upon structures attached to the posterior vitreous cortex, such as new blood vessels that have grown out of the optic disc and/or retina. These events could influence the course of diabetic retinopathy as they may contribute to the proliferation of neovascular frond and perhaps even induce rupture of the new vessels and cause vitreous hemorrhage.
Such molecular effects of diabetes result in morphological changes within the vitreous body, which represent precocious senescence in the vitreous structure ( Fig. 144-9 ). The roles of these and other pathological changes, such as posterior vitreoschisis, are being investigated at present. It is hoped that the future will see therapy designed to inhibit diabetic vitreopathy. Alternatively, the induction of innocuous PVD early in the course of diabetic retinopathy may have long-term salubrious effects in patients at great risk.
This condition features vitreous opacification as a consequence of chronic vitreous hemorrhage. These vitreous opacities are noted when frank hemorrhage is no longer present. They appear as flat, refractile bodies, golden brown in color, and are freely mobile. Associated with liquid vitreous, they settle to the most dependent portion of the vitreous body when eye movement stops. The vitreous about these opacities is degenerated so that collagen is displaced peripherally. Chemical studies demonstrate the presence of cholesterol crystals in these opacities, and the
condition is sometimes referred to as “cholesterolosis bulbi.” Free hemoglobin spherules can occur within the vitreous body.
This generally benign condition is characterized by small yellow-white spherical opacities throughout the vitreous. The prevalence of this condition in the general population is 0.042–0.5%, and it affects all races but with a male-to-female ratio of 2:1. Curiously, asteroid hyalosis is unilateral in over 75% of cases. Asteroid bodies are associated intimately with the vitreous gel and move with typical vitreous displacement during eye movement, which suggests a relationship with collagen fibril degeneration. However, PVD, either complete or partial, occurs less frequently in individuals with asteroid hyalosis than in age-matched controls, which does not support age-related degeneration as a cause. Histological studies demonstrate a crystalline appearance and a pattern of positive staining to fat and acid mucopolysaccharide stains that is not affected by hyaluronidase pretreatment.  Electron diffraction studies showed the presence of calcium oxalate monohydrate and calcium hydroxyphosphate. Ultrastructural studies reveal intertwined ribbons of multilaminar membranes (with a 6?nm periodicity) that are characteristic of complex lipids, especially phospholipids, that lie in a homogeneous background matrix. In these investigations, energy-dispersive X-ray analysis showed calcium and phosphorus to be the main elements in asteroid bodies. Electron diffraction structural analysis demonstrated calcium hydroxyapatite and possibly other forms of calcium phosphate crystals.
Reports exist that suggest an association between asteroid hyalosis and diabetes mellitus.  Other investigators dispute such an association. Asteroid hyalosis appears to be associated with certain pigmentary retinal degenerations,  although it is not known whether this is related to the presence of diabetes in these patients. Yu and Blumenthal proposed that asteroid hyalosis results from aging collagen, whereas other studies  suggested that asteroid formation is preceded by depolymerization of hyaluronan.
Amyloidosis can result in the deposition of opacities in the vitreous of one or both eyes. Bilateral involvement can be an early manifestation of the dominant form of familial amyloidosis, although rare cases of vitreous involvement in nonfamilial forms have been reported. The opacities first appear in the vitreous adjacent to retinal blood vessels and later appear in the anterior vitreous. Initially, the opacities are granular with wispy fringes and later take on a “glass wool” appearance. When the opacities form strands, they appear to attach to the retina and the posterior aspect of the lens by thick footplates. Following PVD, the posterior vitreous cortex is observed to have thick, linear opacities that follow the course of the retinal vessels. The opacities seem to aggregate by “seeding” on vitreous fibrils and along the posterior vitreous cortex. 
Histopathological specimens contain star-like structures with dense, fibrillar centers. The amyloid fibrils are 5–10?nm in diameter and are differentiated from the 10–15?nm vitreous fibrils by stains for amyloid and by the fact that the vitreous fibrils are very straight and long.  Electron microscopy can confirm the presence of amyloid, and immunocytochemical studies identified the major amyloid constituent as a protein that resembles prealbumin.  Streeten proposed that hyalocytes could perform the role of macrophage processing of the amyloid protein before its polymerization. This may further explain why the opacities initially appear at the posterior vitreous cortex where hyalocytes reside.
1. Eisner G. Biomicroscopy of the peripheral fundus. New York: Springer-Verlag; 1973.
2. Worst JGF. Cisternal systems of the fully developed vitreous body in the young adult. Trans Ophthalmol Soc UK. 1977;97:550–4.
3. Sebag J, Balazs EA. Morphology and ultrastructure of human vitreous fibers. Invest Ophthalmol Vis Sci. 1989;30:187–91.
4. Sebag J. The vitreous—structure, function, and pathobiology. New York: Springer-Verlag; 1989.
5. Kishi S, Shimizu K. Posterior precortical vitreous pocket. Arch Ophthalmol. 1990; 108:979–82.
6. Sebag J. Letter to the editor. Arch Ophthalmol. 1991;109:1059–60.
7. Kakehashi A. Age-related changes in the premacular vitreous cortex. Invest Ophthalmol Vis Sci. 1996;37:2253.
8. Seery CM, Davison PF. Collagens of the bovine vitreous. Invest Ophthalmol Vis Sci. 1990;32:1540–50.
9. Bishop PN, Crossman MV, McLeod D. Extraction and characterization of the tissue forms of collagens type II and IX from bovine vitreous. Biochem J. 1994;299:497–505.
10. Bishop PN, Reardon AJ, McLeod D, Ayad S. Identification of alternatively spliced variants of type II procollagen in vitreous. Biochem Biophys Res Commun. 1994;203:289–95.
11. Reardon A, Sandell L, Jones CJP, et al. Localization of pN-type IIA procollagen on adult bovine vitreous collagen fibrils. Matrix Biol. 2000;19:169–73.
12. Zhu Y, Oganesian A, Keene DR, Sandell LJ. Type IIA procollagen containing the cysteine-rich amino propeptide is deposited in the extracellular matrix of prechondrogenic tissue and binds to TGFbeta-1 and BMP-2. J Cell Biol. 1999;144:1069–80.
13. Brewton RG, Ouspenskaia MV, Van der Rest M, Mayne R. Cloning of the chicken alpha 3 (IX) collagen chain completes the primary structure of type IX collagen. Eur J Biochem. 1992;205:443–9.
14. Scott JE. The chemical morphology of the vitreous. Eye. 1992;6:553–5.
15. Zhidkova NI, Justice S, Mayne R. Alternative in RNA processing occurs in the variable region of the pro-peptide. J Biol Chem. 1995;270:9485–93.
16. Bishop PN. Structural macromolecules and supramolecular organization of the vitreous gel. Prog Retinal Eye Res. 2000;19:323–44.
17. Balazs EA. The vitreous. In: Davson H, ed. The eye, Vol la. London: Academic Press; 1984:533–89.
18. Swann DA. Chemistry and biology of the vitreous. Int Rev Exp Pathol. 1980; 22:1–63.
19. Sheehan JK, Atkins EDT, Nieduszynski IA. X-ray diffraction studies on the connective tissue polysaccharides. Two dimensional packing scheme for threefold hyaluronic chains. J Mol Biol. 1975;91:153–63.
20. Chakrabarti B, Park JW. Glycosaminoglycans. Structure and interaction. CRC Crit Rev Biochem. 1980;8:225–313.
21. Brewton RG, Mayne R. Mammalian vitreous humor contains networks of hyaluronan molecules. Exp Eye Res. 1992;198:237–49.
22. Comper WD, Laurent TC. Physiological function of connective tissue polysaccharides. Physiol Rev. 1978;58:255–315.
23. Sebag J. Diabetic vitreopathy. Ophthalmology. 1996;103:205–6.
24. Ogston AG, Phelps CF. The partition of solutes between buffer solutions and solutions containing hyaluronic acid. Biochem J. 1961;78:827–33.
25. Reardon A, Heinegard D, McLeod D, et al. The large chondroitin sulphate proteoglycans versican in mammalian vitreous. Matrix Biol. 1998;17:325–33.
26. Reardon AJ, LeGoff M, Briggs MD, et al. Identification in vitreous and molecular cloning of opticin, a novel member of the family of leucine-rich repeat proteins of the extracellular matrix. J Biol Chem. 2000;275:2123–9.
27. Mayne R, Ren Z-X, Liu J, et al. VIT1—the second member of a new branch of the von Willebrand A domain superfamily. Biochem Soc Trans. 1999;27:832–5.
28. Laicine EM, Haddad A. Transferrin, one of the major vitreous proteins, is produced within the eye. Exp Eye Res. 1994;59:441–5.
29. Brown D, Hamdi H, Bahri S, Kenney MC. Characterization of an endogenous metalloproteinase in human vitreous. Curr Eye Res. 1994;13:639–47.
30. Ueno N, Sebag J, Hirokawa H, Chakrabarti B. Effects of visible light irradiation on vitreous structure in the presence of a photosensitizer. Exp Eye Res. 1987;44: 863–70.
31. Mayne R. The eye. In: Connective tissue and its heritable disorders. New York: Wiley-Liss; 2001:131–41.
32. Tokita M, Fujiya Y, Hikichi K. Dynamic viscoelasticity of bovine vitreous body. Biorheology. 1984;21:751–65.
33. Asakura A. Histochemistry of hyaluronic acid of the bovine vitreous body as studied by electron microscopy. Acta Soc Ophthalmol Jpn. 1985;89:179–91.
34. Hardingham TE. The role of link-protein in the structure of cartilage-proteoglycan aggregates. Biochem J. 1979;177:237–47.
35. Schepens CL, Neetens A, eds. The vitreous and vitreoretinal interface. New York: Springer-Verlag; 1987:20.
36. Sebag J. Age-related changes in human vitreous structure. Graefes Arch Clin Exp Ophthalmol. 1987;225:89–93.
37. Sebag J. Surgical anatomy of vitreous and the vitreo-retinal interface. In: Tasman W, Jaeger E, eds. Clinical ophthalmology, Vol 6. Philadelphia: JB Lippincott; 1994:Ch 51;1–36.
38. Sebag J. Age-related differences in the human vitreo-retinal interface. Arch Ophthalmol. 1991;109:966–71.
39. Sebag J. Anatomy and pathology of the vitreo-retinal interface. Eye. 1992;6:541–52.
40. Gass JDM. Reappraisal of biomicroscopic classification of stages of development of a macular hole. Am J Ophthalmol. 1995;119:752–9.
41. Newsome DA, Linsemayer TF, Trelstad RJ. Vitreous body collagen. Evidence for a dual origin from the neural retina and hyalocytes. J Cell Biol. 1976;71:59–67.
42. Heergaard S, Jensen OA, Prause JU. Structure of the vitreal face of the monkey optic disc. Graefes Arch Clin Exp Ophthalmol. 1988;226:377–83.
43. Lutty GA, Mello RF, Chandler C, et al. Regulation of cell growth by vitreous humor. J Cell Sci. 1985;76:53–65.
44. Snead MP, Yates JRW. Clinical and molecular genetics of Stickler syndrome. J. Med Genet. 1999;36:353–9.
45. Balazs EA, Denlinger JL. Aging changes in the vitreous. In: Aging and human visual function. New York: Alan R Liss; 1982:45–57.
46. Sebag J. Ageing of the vitreous. Eye. 1987;1:254–62.
47. Aguayo J, Glaser BM, Mildvan A, et al. Study of vitreous liquefaction by NMR spectroscopy and imaging. Invest Ophthalmol Vis Sci. 1985;26:692–7.
48. Hageman G, Russel S. Chondroitinase-mediated disinsertion of the primate vitreous body. Invest Ophthalmol Vis Sci. 1994;35:1260.
49. Verstraeten TC, Chapman C, Hartzer M, et al. Pharmacologic induction of posterior vitreous detachment in the rabbit. Arch Ophthalmol. 1993;111:849–54.
50. Teng CC, Chi HH. Vitreous changes and the mechanism of retinal detachment. Am J Ophthalmol. 1957;44:335.
51. Gartner J. Electron microscopic study on the fibrillar network and fibrocyte-collagen interactions in the vitreous cortex at the ora serrata of human eyes with special regard to the role of disintegrating cells. Exp Eye Res. 1986;42:21–33.
52. Wang J, McLeod D, Henson DB, Bishop PN. Age-dependent changes in the basal retinovitreous adhesion. Invest Ophthalmol Vis Sci. 2003;44(5):1793–800.
53. Sebag J. Classifying posterior vitreous detachment—a new way to look at the invisible. Br J Ophthalmol. 1997;81:521.
54. Foos RY. Posterior vitreous detachment. Trans Am Acad Ophthalmol Otolaryngol. 1974;76:480–96.
55. Moore RF. Subjective ‘lightening streak.’ Br J Ophthalmol. 1935:545–50.
56. Wise GN. Relationship of idiopathic preretinal macular fibrosis to posterior vitreous detachment. Am J Ophthalmol. 1975;79:358–61.
57. Voerhoeff FH. Are Moore’s lightening streaks of serious portent? Am J Ophthalmol. 1956;41:837–41.
58. Lindner B. Acute posterior vitreous detachment and its retinal complications. Acta Ophthalmol. 1966;87(Suppl):1–108.
59. Chu T, Lopez PF, Cano MR, et al. Posterior vitreoschisis. An echographic finding in proliferative diabetic retinopathy. Ophthalmology. 1996;103:315–22.
60. Lundquist O, Osterlin S. Glucose concentration in the vitreous of nondiabetic and diabetic human eyes. Graefes Arch Clin Exp Ophthalmol. 1995;232:71–4.
61. Faulborn J, Bowald S. Microproliferations in proliferative diabetic retinopathy and their relation to the vitreous. Graefes Arch Clin Exp Ophthalmol. 1985;223: 130–8.
62. Sebag J. Abnormalities of human vitreous structure in diabetes. Graefes Arch Clin Exp Ophthalmol. 1993;231:257–60.
63. Andrews JS, Lynn C, Scobey JW, Elliot JH. Cholesterolosis bulbi—case report with modern chemical identification of the ubiquitous crystals. Br J Ophthalmol. 1973;57:838–44.
64. Grossniklaus HE, Frank KE, Farbi DC, et al. Hemoglobin spherulosis in the vitreous cavity. Arch Ophthalmol. 1988;106:961–2.
65. Rodman HI, Johnson FB, Zimmerman LE. New histopathological and histochemical observations concerning asteroid hyalitis. Arch Ophthalmol. 1961;66: 552–63.
66. Wasano T, Hirokuwa H, Tagawa H, et al. Asteroid hyalosis—posterior vitreous detachment and diabetic retinopathy. Am J Ophthalmol. 1987;19:255–8.
67. Streeten BA. Disorders of the vitreous. In: Garner A, Klintworth GK, eds. Pathobiology of ocular disease—a dynamic approach, Part B. New York: Marcel Dekker; 1982:1381–419.
68. Smith JL. Asteroid hyalitis—incidence of diabetes mellitus and hypercholesterolemia. JAMA. 1958;168:891–3.
69. Bergren RC, Brown GC, Duker JS. Prevalence and association of asteroid hyalosis with systemic disease. Am J Ophthalmol. 1991;111:289–93.
70. Hatfield RE, Gastineau CF, Rucke CW. Asteroid bodies in the vitreous—relationship to diabetes and hypercholesterolemia. Mayo Clin Proc. 1962;37:513–14.
71. Sebag J, Albert DM, Craft JL. The Alström syndrome—ocular histopathology and retinal ultrastructure. Br J Ophthalmol. 1984;68:494–501.
72. Yu SY, Blumenthal HT. The calcification of elastic tissue. In: Wagner BM, Smith DE, eds. The connective tissue. Baltimore: Williams & Wilkins; 1967:17–49.
73. Lamba PA, Shukla KM. Experimental asteroid hyalopathy. Br J Ophthalmol. 1971;55:279–83.
74. Doft BH, Rubinow A, Cohen AS. Immunocytochemical demonstration of prealbumin in the vitreous in heredofamilial amyloidosis. Am J Ophthalmol. 1984:97:296–300.